Fmr LLC Bluebird Bio, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,295,062 shares of BLUE stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,295,062

Previous 2,380,610 3.59%

Holding current value

$1.08 Million

Previous $3.05 Million 26.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.85 - $1.26 $72,715 - $107,790	-85,548 Reduced 3.59%	2,295,062 $2.25 Million
Q1 2024 May 13, 2024	BUY	$0.91 - $1.75 $3,680 - $7,077	4,044 Added 0.17%	2,380,610 $3.05 Million
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $2.92 Million - $10.7 Million	2,211,345 Added 1338.42%	2,376,566 $3.28 Million
Q3 2023 Nov 13, 2023	BUY	$3.02 - $4.05 $33,467 - $44,882	11,082 Added 7.19%	165,221 $502,000
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $125,683 - $226,591	45,048 Added 41.29%	154,139 $507,000
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $1,271 - $3,329	405 Added 0.37%	109,091 $346,000
Q4 2022 Feb 13, 2023	SELL	$5.77 - $8.49 $8,833 - $12,998	-1,531 Reduced 1.39%	108,686 $752,000
Q3 2022 Nov 10, 2022	BUY	$3.75 - $7.39 $11,640 - $22,938	3,104 Added 2.9%	110,217 $698,000
Q2 2022 Aug 12, 2022	BUY	$2.94 - $5.23 $3,989 - $7,097	1,357 Added 1.28%	107,113 $443,000
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $430,386 - $1.12 Million	105,746 Added 1057460.0%	105,756 $513,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $188 - $342	-21 Reduced 67.74%	10 $0
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $139,758 - $261,114	-12,434 Reduced 99.75%	31 $0
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $224,868 - $275,351	12,465 New	12,465 $258,000

Others Institutions Holding BLUE

# of Institutions

161

Shares Held

80M

Call Options Held

525K

Put Options Held

634K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $36.2M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account